SCHEMBL6958720

SCHEMBL6958720

CC(C)c1ccc2c[c][nH]c2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EIF4A3 P38919 3/20 0.45
KIF11 P52732 1/20 0.42
SCN10A Q9Y5Y9 1/20 0.37
LMNA P02545 1/20 0.36
HTT P42858 2/20 0.35
TRPA1 O75762 1/20 0.35
PTGS1 P23219 1/20 0.35
CACNA1C Q13936 1/20 0.35
ALDH1A1 P00352 2/20 0.34
GAA P10253 2/20 0.34
UGT2B7 P16662 1/20 0.34
ALOX12 P18054 1/20 0.34
HIF1A Q16665 1/20 0.34
KDM4E B2RXH2 3/20 0.34
MEN1 O00255 1/20 0.34
F2 P00734 1/20 0.34
MAPT P10636 1/20 0.34
KMT2A Q03164 1/20 0.34
HTR1D P28221 2/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL181347 0.70 UGT2B7 (0.58) EIF4A3LMNAHTTTRPA1PTGS1
SCHEMBL30031337 0.70 UGT2B7 (0.58) EIF4A3LMNAHTTTRPA1PTGS1
SCHEMBL4832080 0.70 UGT2B7 (0.52) EIF4A3KIF11LMNAHTTTRPA1
SCHEMBL83970 0.69 AHR (0.50) EIF4A3KIF11TRPA1ALDH1A1KDM4E
SCHEMBL207534 0.68 AHR (0.48) LMNAHTTALDH1A1KDM4EMEN1
SCHEMBL6959510 0.68 TYR (0.48) LMNAGAAHIF1AMEN1KMT2A
SCHEMBL207104 0.68 AHR (0.48) LMNAALDH1A1KDM4EHPGDHSD17B10
SCHEMBL2756054 0.68 EIF4A3 (0.57) EIF4A3KIF11SCN10ALMNAHTT
SCHEMBL6958413 0.68 CYP1A2 (0.45) KIF11LMNATRPA1ALDH1A1KDM4E
SCHEMBL3265231 0.68 EIF4A3 (0.57) EIF4A3KIF11SCN10ALMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6333339-B1 CENTRAL SYSTEM DISORDERS, SCHIZOPHRENIA AND COGNITION ACTIVATORS MERCK PATENT GELLSCHAFT MIT BESCHRANKTER (DE) 2001-12-25 US claimed
EP-0993458-B1 3-BENZYLPIPERIDINE MERCK PATENT GMBH (DE) 2003-04-09 EP disclosed
US-6333339-B1 CENTRAL SYSTEM DISORDERS, SCHIZOPHRENIA AND COGNITION ACTIVATORS MERCK PATENT GELLSCHAFT MIT BESCHRANKTER (DE) 2001-12-25 US disclosed
EP-0998474-A1 PIPERAZINE DERIVATIVES MERCK PATENT GmbH (DE) 2000-05-10 EP disclosed
EP-0993458-A1 3-BENZYLPIPERIDINE MERCK PATENT GmbH (DE) 2000-04-19 EP disclosed
WO-1999003855-A1 PIPERAZINE DERIVATIVES MERCK PATENT GMBH (DE) 1999-01-28 WO disclosed
WO-1998057953-A1 3-BENZYLPIPERIDINE MERCK PATENT GMBH (DE) 1998-12-23 WO disclosed